Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 14, 2017

Primary Completion Date

August 21, 2020

Study Completion Date

August 22, 2022

Conditions
Resectable Pancreatic Adenocarcinoma
Interventions
DEVICE

Intraoperative radiation therapy (IORT)

IORT with 50 kV x-ray will be delivered during surgery as a single dose of 10 Gy at 5 millimeter depths of the tumor bed, followed by gemcitabine chemotherapy (1000 mg/m2) every 4 weeks for a total of 6 cycles

Trial Locations (1)

Unknown

Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT03273374 - Intraoperative Radiation Therapy for Resectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter